AGP Executive Report
Last update: 3 hours agoMS Drug Access: Dutch regulator ACM is investigating Biogen over whether it unlawfully restricts access to a serious-brain-disorder risk test to patients taking its MS drug Tysabri, potentially limiting treatment choice. Donor Limits: A Dutch sperm donor who fathered at least 199 children has signed an agreement barring further donations, with remaining clinic-stored sperm to be destroyed. Infectious Disease: Dutch West Nile cases have reached 77, with two more deaths reported. Diabetes Care: An app used in Dutch hospitals has reportedly cut diabetes check-ups by up to 64%. Dutch Pharma: Leiden-based Pharming’s Joenja has won UK approval as a treatment for children with a rare immune disorder.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.